Century Therapeutics IPSC
NASDAQ IPSC
$1.71 +0.06 (+3.33%)
As of: Sep 30, 2026 · 3:59 PM EDT

Century Therapeutics (IPSC) Total Debt (2020 - 2023)

Updated

Century Therapeutics' Total Debt came in at $10.3 million for Q1 2023, up 2.8% from $10.02 million a year earlier and up 0.5% from the prior quarter.

Analysis

Century Therapeutics (IPSC) Total Debt (2020 - 2023) Analysis & Trends

At the end of FY2022, Century Therapeutics' Total Debt was $10.24 million, up 3.0% from FY2021.

  • Going back by year, Total Debt was $9.94 million in FY2021 (+3.2%) and $9.64 million in FY2020.
  • Business Quant data shows IPSC's Total Debt at $10.24 million (Q4 2022), $10.17 million (Q3 2022) and $10.1 million (Q2 2022) in the three quarters before Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 49.04 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 70.82 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -111.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Century Therapeutics 297.90 Mn -206.47 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 10.30 Mn
Dec 31, 2022 10.24 Mn
Sep 30, 2022 10.17 Mn
Jun 30, 2022 10.10 Mn
Mar 31, 2022 10.02 Mn
Dec 31, 2021 9.94 Mn
Dec 31, 2020 9.64 Mn
API Access

Century Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=IPSC&period=max&api_key=YOUR_API_KEY